| Period Ending | 31-Mar-2009 |
|---|
|
Total Revenue
|
3,057,000
| | Cost of Revenue | 1,997,000 | | |
Gross Profit
|
1,060,000
| |
|
Operating Expenses |
|
Research Development |
-
|
|
Selling General and Administrative |
-
|
|
Non Recurring |
-
|
|
Others |
-
|
|
|
|
Total Operating Expenses | 2,816,000 | | | |
Operating Income or Loss
|
241,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
|
Earnings Before Interest And Taxes | 241,000 |
|
Interest Expense | (245,000) |
|
Income Before Tax |
-
|
|
Income Tax Expense | 2,000 |
|
Minority Interest |
-
|
|
|
|
Net Income From Continuing Ops | (4,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
|
Extraordinary Items |
-
|
|
Effect Of Accounting Changes |
-
|
|
Other Items |
-
| | | |
Net Income
|
(4,000)
| | Preferred Stock And Other Adjustments |
-
| | |
Net Income Applicable To Common Shares
|
-
|
|
36.10(100.00%) 10:14AM